Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ehrlich

Showing results (61-70 of 864) with videos related to

Pageof 87
Sort By:
Science (New York, N.Y.)|June 9, 2018
The misunderstood sixth mass extinctionGerardo Ceballos, Paul R Ehrlich
Drugs|May 16, 2009
Novel approaches for pharmacological management of atrial fibrillationJoachim R Ehrlich, Stanley Nattel
Science (New York, N.Y.)|June 30, 2001
New world pathogen strategy disclosedT Eisner, P R Ehrlich
Pathobiology Annual|January 1, 1982
Natural killer cells and naturally occurring antibodies as representatives of natural tumor immunityR Ehrlich, I P Witz
The Annals of Pharmacotherapy|September 1, 1993
Acute pulmonary edema after polyethylene glycol intestinal lavage in a childC M Paap, R Ehrlich
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2023
Mutilation of the tree of life via mass extinction of animal generaGerardo Ceballos, Paul R Ehrlich
Nucleic Acids Research|March 25, 1988
Far upstream sequences of the bla promoter from TN3 are involved in complexation with E. coli RNA-polymeraseG Duval-Valentin, R Ehrlich
Nucleic Acids Research|January 26, 1987
Dynamic and structural characterisation of multiple steps during complex formation between E. coli RNA polymerase and the tetR promoter from pSC101G Duval-Valentin, R Ehrlich
International Journal of Cardiology|February 11, 2021
Therapy-refractory AF: A clear unmet need for the development of novel antiarrhythmic drugsJoachim R Ehrlich, Dobromir Dobrev
Journal of Immunological Methods|January 1, 1979
The elution of antibodies from viable murine tumor cellsR Ehrlich, I P Witz
Pageof 87

Showing results (61-70 of 864) with videos related to

Sort By:
Pageof 87
Science (New York, N.Y.)|June 9, 2018
The misunderstood sixth mass extinctionGerardo Ceballos, Paul R Ehrlich
Drugs|May 16, 2009
Novel approaches for pharmacological management of atrial fibrillationJoachim R Ehrlich, Stanley Nattel
Science (New York, N.Y.)|June 30, 2001
New world pathogen strategy disclosedT Eisner, P R Ehrlich
Pathobiology Annual|January 1, 1982
Natural killer cells and naturally occurring antibodies as representatives of natural tumor immunityR Ehrlich, I P Witz
The Annals of Pharmacotherapy|September 1, 1993
Acute pulmonary edema after polyethylene glycol intestinal lavage in a childC M Paap, R Ehrlich
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2023
Mutilation of the tree of life via mass extinction of animal generaGerardo Ceballos, Paul R Ehrlich
Nucleic Acids Research|March 25, 1988
Far upstream sequences of the bla promoter from TN3 are involved in complexation with E. coli RNA-polymeraseG Duval-Valentin, R Ehrlich
Nucleic Acids Research|January 26, 1987
Dynamic and structural characterisation of multiple steps during complex formation between E. coli RNA polymerase and the tetR promoter from pSC101G Duval-Valentin, R Ehrlich
International Journal of Cardiology|February 11, 2021
Therapy-refractory AF: A clear unmet need for the development of novel antiarrhythmic drugsJoachim R Ehrlich, Dobromir Dobrev
Journal of Immunological Methods|January 1, 1979
The elution of antibodies from viable murine tumor cellsR Ehrlich, I P Witz
Pageof 87